SCHEMBL339752

SCHEMBL339752

C/C(=C\Cc1ccc(O)c(O)c1)C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.49
KDM4E B2RXH2 9/20 0.46
HSD17B10 Q99714 8/20 0.46
ALOX15 P16050 8/20 0.46
TDP1 Q9NUW8 7/20 0.46
HIF1A Q16665 6/20 0.46
RECQL P46063 6/20 0.46
PTGS1 P23219 3/20 0.46
USP2 O75604 3/20 0.46
PTGS2 P35354 3/20 0.46
EGFR P00533 2/20 0.46
FYN P06241 2/20 0.46
ADORA3 P0DMS8 2/20 0.46
HTR2A P28223 2/20 0.46
LCK P06239 2/20 0.46
SLC7A5 Q01650 1/20 0.46
MAPT P10636 7/20 0.45
HPGD P15428 6/20 0.45
ALDH1A1 P00352 6/20 0.45
BLM P54132 5/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL339754 1.00 XDH (0.49) XDHKDM4EHSD17B10ALOX15TDP1
SCHEMBL29655817 0.84 KDM4E (0.50) KDM4EHSD17B10ALOX15TDP1HIF1A
SCHEMBL400289 0.84 KDM4E (0.50) KDM4EHSD17B10ALOX15TDP1HIF1A
SCHEMBL3870569 0.83 ALDH1A1 (0.41) KDM4EHSD17B10ALOX15TDP1HIF1A
SCHEMBL29764187 0.81 ALOX15 (0.51) KDM4EHSD17B10ALOX15TDP1HIF1A
SCHEMBL3869765 0.81 CA2 (0.47) KDM4ESLC7A5ALDH1A1BLMTRPA1
SCHEMBL1291989 0.78 XDH (0.59) XDHKDM4EHSD17B10ALOX15TDP1
SCHEMBL1788431 0.77 IDO1 (0.43) ALDH1A1LMNATRPA1CYP1A2TAAR1
SCHEMBL554390 0.75 ALDH1A1 (0.42) TDP1PTGS1SLC7A5HPGDALDH1A1
SCHEMBL554389 0.75 ALDH1A1 (0.42) TDP1PTGS1SLC7A5HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367091-B2 Coatings for implantable medical devices ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2013-02-05 US disclosed
US-8097268-B2 Coatings for implantable medical devices ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2012-01-17 US disclosed
US-20090252780-A1 COATINGS FOR IMPLANTABLE MEDICAL DEVICES ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2009-10-08 US disclosed
US-20090248146-A1 COATINGS FOR IMPLANTABLE MEDICAL DEVICES ADVANCED CARDIOVASCULAR SYSTEMS, INC. 2009-10-01 US disclosed
US-7563454-B1 Coatings for implantable medical devices ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2009-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090252780-A1 COATINGS FOR IMPLANTABLE MEDICAL DEVICES AOC1, TFRC, CD59 XDH 1739/4885KDM4E 1741/4885HSD17B10 4681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.